Albertas Ulys

2.4k total citations · 1 hit paper
64 papers, 1.4k citations indexed

About

Albertas Ulys is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Albertas Ulys has authored 64 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Pulmonary and Respiratory Medicine, 16 papers in Oncology and 15 papers in Molecular Biology. Recurrent topics in Albertas Ulys's work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Albertas Ulys is often cited by papers focused on Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (19 papers) and Radiopharmaceutical Chemistry and Applications (10 papers). Albertas Ulys collaborates with scholars based in Lithuania, United States and France. Albertas Ulys's co-authors include Mindaugas Jievaltas, Karim Fizazi, Egils Vjaters, Toni Sarapohja, Amir Snapir, Neal D. Shore, Teuvo L.J. Tammela, B. Yа. Alekseev, Murilo Luz and S. Polyakov and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Albertas Ulys

63 papers receiving 1.4k citations

Hit Papers

Darolutamide in Nonmetastatic, Castration-Resistant Prost... 2019 2026 2021 2023 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer
    2019 579 citations Karim Fizazi, Neal D. Shore et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Albertas Ulys Lithuania 16 1.1k 459 337 323 282 64 1.4k
Iris Kuss Germany 12 1.1k 1.0× 400 0.9× 400 1.2× 251 0.8× 171 0.6× 40 1.3k
Mindaugas Jievaltas Lithuania 14 1.0k 0.9× 304 0.7× 284 0.8× 217 0.7× 181 0.6× 65 1.3k
Murilo Luz Brazil 7 952 0.8× 324 0.7× 303 0.9× 199 0.6× 173 0.6× 34 1.1k
Ronald Tutrone United States 21 1.1k 1.0× 398 0.9× 179 0.5× 226 0.7× 426 1.5× 111 1.7k
Vahid Naini United States 8 1.1k 1.0× 357 0.8× 417 1.2× 244 0.8× 138 0.5× 21 1.2k
Andrea Juliana Gomes United States 8 1.4k 1.2× 450 1.0× 496 1.5× 336 1.0× 152 0.5× 24 1.5k
Angela Lopez‐Gitlitz United States 14 1.8k 1.6× 587 1.3× 676 2.0× 368 1.1× 235 0.8× 62 1.9k
De Phung United States 19 1.7k 1.5× 612 1.3× 618 1.8× 495 1.5× 289 1.0× 46 2.0k
Álvaro Juárez Soto Spain 8 1.1k 0.9× 345 0.8× 379 1.1× 222 0.7× 116 0.4× 44 1.2k
Sharon McCarthy United States 8 962 0.9× 326 0.7× 341 1.0× 217 0.7× 117 0.4× 28 1.1k

Countries citing papers authored by Albertas Ulys

Since Specialization
Citations

This map shows the geographic impact of Albertas Ulys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Albertas Ulys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Albertas Ulys more than expected).

Fields of papers citing papers by Albertas Ulys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Albertas Ulys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Albertas Ulys. The network helps show where Albertas Ulys may publish in the future.

Co-authorship network of co-authors of Albertas Ulys

This figure shows the co-authorship network connecting the top 25 collaborators of Albertas Ulys. A scholar is included among the top collaborators of Albertas Ulys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Albertas Ulys. Albertas Ulys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nainys, Juozas, Simonas Juzėnas, Darius Dasevičius, et al.. (2024). Single-cell transcriptional profiling of clear cell renal cell carcinoma reveals a tumor-associated endothelial tip cell phenotype. Communications Biology. 7(1). 780–780. 10 indexed citations
2.
Sabaliauskaitė, Rasa, et al.. (2023). Germline DNA Damage Response Gene Mutations in Localized Prostate Cancer. Medicina. 60(1). 73–73. 1 indexed citations
3.
Shore, Neal D., Murilo Luz, Albertas Ulys, et al.. (2023). Long-term safety and tolerability of darolutamide and duration of treatment in patients with nonmetastatic castration-resistant prostate cancer (nmCRPC) from the ARAMIS Rollover Study.. Journal of Clinical Oncology. 41(6_suppl). 147–147. 3 indexed citations
4.
5.
Ulys, Albertas, et al.. (2021). A Refinement of Clinical Tumor Marker Monitoring: Why Not Use an Inverse Value of Doubling Time?. Medical Principles and Practice. 30(3). 292–296. 1 indexed citations
6.
Klotz, Laurence, N. Axén, Cecilia Wassberg, et al.. (2021). Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients. European Urology Focus. 8(1). 112–120. 3 indexed citations
7.
Bakavičius, Arnas, et al.. (2021). Clinical Significance of ADAMTS19, BMP7, SIM1, and SFRP1 Promoter Methylation in Renal Clear Cell Carcinoma. OncoTargets and Therapy. Volume 14. 4979–4990. 3 indexed citations
8.
Žukauskaitė, Kristina, Albertas Ulys, Rasa Sabaliauskaitė, et al.. (2021). Clinical significance of novel DNA methylation biomarkers for renal clear cell carcinoma. Journal of Cancer Research and Clinical Oncology. 148(2). 361–375. 17 indexed citations
9.
10.
Bakavičius, Arnas, et al.. (2020). Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection. BioMed Research International. 2020(1). 9872146–9872146. 25 indexed citations
11.
Sabaliauskaitė, Rasa, Arnas Bakavičius, Benedikta S. Haflidadóttir, et al.. (2020). Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate. The Journal of Urology. 204(1). 71–78. 12 indexed citations
12.
Kinčius, Marius, et al.. (2019). Sternal resection of a solitary renal cell carcinoma metastasis: a case report and a literature review. SHILAP Revista de lepidopterología. 25(4). 226–233. 3 indexed citations
13.
Patašius, Aušvydas, Agnė Ulytė, Albertas Ulys, & Giedrė Smailytė. (2019). Trends in the incidence and mortality of kidney cancer in Lithuania from 1993 to 2012. SHILAP Revista de lepidopterología. 25(3). 151–160. 3 indexed citations
14.
Daniūnaitė, Kristina, Arnas Bakavičius, Juozas Rimantas Lazutka, et al.. (2017). Clinical significance of miRNA host gene promoter methylation in prostate cancer. Human Molecular Genetics. 26(13). 2451–2461. 49 indexed citations
15.
16.
Fizazi, Karim, Albertas Ulys, Lisa Sengeløv, et al.. (2016). A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod (TASQ) in patients (pts) with mCRPC responsive to or stabilized during first-line docetaxel chemotherapy.. Journal of Clinical Oncology. 34(2_suppl). 201–201. 1 indexed citations
17.
Gondos, Ádám, Agnė Krilavičiūtė, Giedrė Smailytė, Albertas Ulys, & Hermann Brenner. (2015). Cancer surveillance using registry data: Results and recommendations for the Lithuanian national prostate cancer early detection programme. European Journal of Cancer. 51(12). 1630–1637. 20 indexed citations
18.
19.
Didžiapetrienė, Janina, et al.. (2012). Antioxidative system parameters and level of IL-18 after surgery in patients with renal cell carcinoma according to gender. Acta Physiologica Hungarica. 100(1). 107–114. 2 indexed citations
20.
Samalavičius, Narimantas Evaldas, Raimundas Lunevičius, Rakesh Kumar Gupta, Tomas Poškus, & Albertas Ulys. (2012). Gracilis muscle interposition with primary rectal without urethral repair for moderate sized rectourethral fistula caused by brachytherapy for prostate cancer: a case report. Journal of Medical Case Reports. 6(1). 323–323. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Iris Kuss Breakdown of academic impact, for papers by Mindaugas Jievaltas Breakdown of academic impact, for papers by Murilo Luz Breakdown of academic impact, for papers by Ronald Tutrone Breakdown of academic impact, for papers by Vahid Naini Breakdown of academic impact, for papers by Andrea Juliana Gomes Breakdown of academic impact, for papers by Angela Lopez‐Gitlitz Breakdown of academic impact, for papers by De Phung Breakdown of academic impact, for papers by Álvaro Juárez Soto Breakdown of academic impact, for papers by Sharon McCarthy
Rankless by CCL
2026